See Deeper. Care Better.

High-Frequency Ultrasound Imaging for Evidence-Based Skin Treatments

Ready for Purchase.

Products

The SkinScanner device held in hand.

High-resolution ultrasound imaging for evidence-based skin treatments. Currently available for pre-clinical, clinical and aesthetic applications in certain regions. MDR CE Class IIa certification is pending.

  • Dermoscopy guidance with 12x12 mm optical field of view

  • Highest frequency handheld ultrasound on the market (20-40 MHz, ≤10 mm depth)

  • Proprietary and patent-pending technology with registered design

  • Easy interpretation with positioning line

  • Precise image positioning and reproducibility

  • 1-D Power Doppler mode

  • Affordable point-of-care

 Research package for evidence-based skin treatment analysis.

  • AI-based skin layer segmentation

  • Quantification of skin changes

  • Efficient patient management with anonymized data collection

  • Web-based platform offering cloud or local storage

  • Advanced filters, settings, and annotation tools

  • Third-party image import

  • Two-point distance measurement and volume estimation

Technology

good

poor

Imaging

Speed

Portability

Resolution

Depth

Affordability

Dermoscopy

OCT

HFUS

SkinScanner

Optics

Laser

Ultrasound

Optics + Ultrasound

Technology

Applications

Selected Publications

History

2018

Dermus founded as a spin-off company of Pázmány Péter Catholic University

2019

Dermus receives first seed investment round

2020

Clinical trial of Dermus SkinScanner device launched at Semmelweis Medical University

2021

Dermus data-based scan conversion patent granted in US (US10928515B2)

Patent submission for dermoscopy-guided ultrasound imaging technology

2022

First commercial sale of SkinScanner for research

First research paper on clinical experience with dermoscopy-guided ultrasound imaging

2023

Launch of skin structure segmentation on ultrasound images for research use

First independent investigations validating use of SkinScanner for melanoma staging and basal cell carcinoma subtype differentiation

Upcoming Events

Collaborations

We are always happy to collaborate with universities, CROs, pharmaceutical and other companies to support evidence-based skin therapies that look beyond the surface. Feel free to get in touch below.